Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity

NCT00651729 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
279
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan